(Q39564978)

13 September 2017

title

Murine rhabdomyosarcoma is immunogenic and responsive to T-cell-based immunotherapy (English)

1 reference

13 September 2017

1 reference

1 reference

Joanna L Meadors

1

1 reference

13 September 2017

Yonghzi Cui

2

1 reference

13 September 2017

Qing-Rong Chen

3

1 reference

13 September 2017

Young K Song

4

1 reference

13 September 2017

Javed Khan

5

1 reference

13 September 2017

Glenn Merlino

6

1 reference

13 September 2017

Maria Tsokos

7

1 reference

13 September 2017

Rimas J Orentas

8

1 reference

13 September 2017

Crystal L Mackall

9

1 reference

13 September 2017

publication date

1 April 2011

1 reference

13 September 2017

published in

Pediatric Blood Cancer

1 reference

13 September 2017

volume

57

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

921-929

1 reference

Irinotecan for pediatric solid tumors: the Memorial Sloan-Kettering experience

13 September 2017

cites work

1 reference

Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.

21 January 2018

1 reference

Chronic health conditions in adult survivors of childhood cancer

21 January 2018

1 reference

Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4

21 January 2018

1 reference

Infusion of donor peripheral blood mononuclear cells to treat relapse after transplantation for chronic myelogenous leukemia

21 January 2018

1 reference

Lessons from randomized phase III studies with active cancer immunotherapies--outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC).

21 January 2018

1 reference

Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation

21 January 2018

1 reference

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group

21 January 2018

1 reference

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

21 January 2018

1 reference

Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis.

21 January 2018

1 reference

Metagene projection for cross-platform, cross-species characterization of global transcriptional states

21 January 2018

1 reference

A molecular map of mesenchymal tumors

21 January 2018

1 reference

Molecular characterization of the pediatric preclinical testing panel

21 January 2018

1 reference

Diagnosis of the small round blue cell tumors using multiplex polymerase chain reaction

21 January 2018

1 reference

Defining the gene expression signature of rhabdomyosarcoma by meta-analysis.

21 January 2018

1 reference

Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches

21 January 2018

1 reference

Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

21 January 2018

1 reference

Partial CD4 depletion reduces regulatory T cells induced by multiple vaccinations and restores therapeutic efficacy.

21 January 2018

1 reference

Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts

21 January 2018

1 reference

Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma

21 January 2018

1 reference

Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma.

21 January 2018

1 reference

Absolute lymphocyte count predicts overall survival in follicular lymphomas.

21 January 2018

1 reference

Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer

21 January 2018

1 reference

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

21 January 2018

1 reference

Suppression of anti-cancer immunity by regulatory T cells: back to the future

21 January 2018

1 reference

Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators

21 January 2018

1 reference

Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma

21 January 2018

1 reference

Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2beta as biomarkers for rhabdomyosarcoma diagnostics

21 January 2018

1 reference

Dual expression of CD80 and CD86 produces a tumor vaccine superior to single expression of either molecule.

21 January 2018

1 reference

Immune surveillance of tumors

21 January 2018

1 reference

Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma

21 January 2018

1 reference

Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response

21 January 2018

1 reference

Lymphocyte depletion during treatment with intensive chemotherapy for cancer

21 January 2018

1 reference

12 December 2020

Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression.

1 reference

12 December 2020

Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells

1 reference

12 December 2020

Continuous interleukin-2 and lymphokine-activated killer cells for advanced cancer: a National Biotherapy Study Group trial

1 reference

12 December 2020

CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma

1 reference

12 December 2020

CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma

1 reference

12 December 2020

Growth of tumor-infiltrating lymphocytes from human solid cancers: summary of a 5-year experience

1 reference

12 December 2020

Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study

1 reference

12 December 2020

Early lymphocyte recovery in Ewing sarcoma

1 reference

12 December 2020

Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group

1 reference

12 December 2020

Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma.

1 reference

12 December 2020

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

12 December 2020

Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group

1 reference

12 December 2020

Immune reconstitution prevents metastatic recurrence of murine osteosarcoma

1 reference

12 December 2020

Identifiers

DOI

10.1002/PBC.23048

1 reference

release_wb7fsecqovhsppbwvdz7zyi3uy

13 September 2017

Fatcat ID

0 references

PMC publication ID

7401311

0 references

1 reference